Gastroesophageal reflux disease (GERD) affects an estimated 1.03 billion people worldwide, with prevalence ranging significantly by region. Defined as a condition where stomach contents reflux causes troublesome symptoms like heartburn and regurgitation, GERD’s diagnosis often involves endoscopy and reflux monitoring, especially for patients unresponsive to initial treatments. Advanced diagnostic tools such as pH or impedance-pH monitoring and high-resolution esophageal manometry help clinicians confirm GERD and assess for surgical suitability in more severe cases. Evolving treatments include tailored use of proton pump inhibitors (PPIs), novel medical therapies, and endoscopic procedures. Explore the full article for a comprehensive review of diagnostic and management strategies that are helping clinicians better address this pervasive condition.
Trending
- Evaluating the analytical performance of direct-to-consumer gut microbiome testing services (Nature)
- Resecting a Rectal Carcinoid (GI & Endoscopy News)
- AI blood test detects early pancreatic cancer with up to 94% accuracy (Medical Xpress)
- Why 2026 is a reset year for U.S. health care (Medical Economics)
- The “Dream Team” for Managing IBS-C Needs GI Psychologist and Dietician (Gastroenterology Learning Network)
- March 2026 issue Of The American Journal of Gastroenterology (The American Journal of Gastroenterology)
- The GI physician shortage by state, by 2036 (Becker’s GI & Endoscopy)
- PAGI Joins UPMC to Expand Access to Specialized Gastroenterology Care in Central Pa. (UPMC)
